- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | ZHONG JI LS (00767): FURTHER DELAY IN DESPATCH OF CIRCULAR MAJOR AND CONNECTED TRANSACTION IN RELATION TO ACQUISITION OF 25% ISSUED SHARE CAPITAL OF ASIAN ... | - | HKEx | ||
| 27.08. | ZHONG JI LS (00767): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026 | 1 | HKEx | ||
| 27.08. | ZHONG JI LS (00767): CHANGE OF ADDRESS OF THE REGISTERED OFFICE AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG | - | HKEx | ||
| 21.08. | ZHONG JI LS (00767): FURTHER DELAY IN DESPATCH OF CIRCULAR MAJOR AND CONNECTED TRANSACTION IN RELATION TO ACQUISITION OF 25% ISSUED SHARE CAPITAL OF ASIAN ... | 1 | HKEx | ||
| 21.08. | ZHONG JI LS (00767): MAJOR AND CONNECTED TRANSACTION IN RELATION TO ACQUISITION OF 25% ISSUED SHARE CAPITAL OF ASIAN INTEGRATED CELL LABORATORY LIMITED ... | 1 | HKEx | ||
| 17.08. | ZHONG JI LS (00767): DATE OF BOARD MEETING | - | HKEx | ||
| ZHONG JI LONGEVITY SCIENCE GROUP Aktie jetzt für 0€ handeln | |||||
| 07.07. | ZHONG JI LS (00767): VOLUNTARY ANNOUNCEMENT MEMORANDUM OF COOPERATION | 1 | HKEx | ||
| 02.07. | ZHONG JI LS (00767): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2025 | 1 | HKEx | ||
| 30.06. | ZHONG JI LS (00767): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 JUNE 2026 | 3 | HKEx | ||
| 10.06. | ZHONG JI LS (00767): FURTHER DELAY IN DESPATCH OF CIRCULAR MAJOR AND CONNECTED TRANSACTION IN RELATION TO ACQUISITION OF 25% ISSUED SHARE CAPITAL OF ASIAN ... | - | HKEx | ||
| 08.06. | ZHONG JI LS (00767): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CIRCULAR OF ANNUAL GENERAL MEETING 2025 | - | HKEx | ||
| 08.06. | ZHONG JI LS (00767): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CIRCULAR AND PROXY FORM OF ANNUAL GENERAL ... | - | HKEx | ||
| 08.06. | ZHONG JI LS (00767): NOTICE OF THE ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 08.06. | ZHONG JI LS (00767): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING | - | HKEx | ||
| 08.06. | ZHONG JI LS (00767): PROPOSAL ON (1) RE-ELECTION OF RETIRING DIRECTORS, (2) RE-APPOINTMENT OF AUDITOR, (3) GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE ... | - | HKEx | ||
| 30.04. | ZHONG JI LS (00767): FURTHER DELAY IN DESPATCH OF CIRCULAR MAJOR AND CONNECTED TRANSACTION IN RELATION TO ACQUISITION OF 25% ISSUED SHARE CAPITAL OF ASIAN ... | - | HKEx | ||
| 27.04. | ZHONG JI LS (00767): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF ANNUAL REPORT 2025 | 2 | HKEx | ||
| 27.04. | ZHONG JI LS (00767): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF ANNUAL REPORT 2025 | 2 | HKEx | ||
| 27.04. | ZHONG JI LS (00767): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | 1 | HKEx | ||
| 27.04. | ZHONG JI LS (00767): ANNUAL REPORT 2025 | 2 | HKEx |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 48,090 | -1,94 % | Platzt der Knoten?: Bayer-Aktie vor dem wichtigsten Glyphosat-Termin der Unternehmensgeschichte? | © Foto: KI-generiert mit DALL-EVor fast 10 Jahren hat Bayer Monsanto übernommen. Damals hat wohl niemand in Leverkusen damit gerechnet, dass eine jahrelange Prozessflut damit verbunden ist. Biegt die... ► Artikel lesen | |
| MERCK KGAA | 129,85 | -1,22 % | Community-Rückblick: "Moderna wäre um min. 50% gestiegen, BioNTech bisher nicht mal 2%. That's it!" | © Foto: Julia Cebella - dpaNeue Onkologie-Daten sorgen bei BioNTech für Diskussionen: Warum reagiert die Aktie trotz guter Studienergebnisse kaum? Die wO User Diskutieren über Pipeline, Bewertung und... ► Artikel lesen | |
| IM CANNABIS CORP | 4,200 | -0,71 % | IM Cannabis Stock Surges 247% | ||
| NOVO NORDISK | 37,580 | -0,12 % | Novo Nordisk öffnet GLP-1 die nächste Tür - warum Big Pharma Milliardenmärkte immer weiter vergrößert | ||
| DERMAPHARM | 38,900 | -0,26 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| KARDIGAN | 16,620 | -0,12 % | Citi's U.S. Consumer Cards Business To Buy Kard Financial For Undisclosed Terms | WASHINGTON (dpa-AFX) - Banking major Citigroup Inc. (C) announced late Thursday that its U.S. Consumer Cards business has agreed to acquire Kard Financial, a commerce media and rewards platform.... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 17,150 | 0,00 % | Generate Biomedicines auf der H.C. Wainwright Konferenz: Plattform-Strategie im Fokus | ||
| LB PHARMACEUTICALS | 42,370 | -0,24 % | LB Pharmaceuticals Appoints Susan Kozauer As CMO | ||
| ETON PHARMACEUTICALS | 55,48 | 0,00 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| APNIMED | 29,020 | +0,07 % | Apnimed, Inc.: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update | U.S. Food and Drug Administration ("FDA") Accepted the NDA for AD109, with a proposed proprietary name Oxnimbi- and assigned a PDUFA target action date of February 28,- 2027 If approved, Oxnimbi... ► Artikel lesen | |
| SCHOTT PHARMA | 23,450 | +1,08 % | JPMORGAN stuft Schott Pharma auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Bewertung von Schott Pharma beim Kursziel von 27,10 Euro mit "Overweight" aufgenommen. Der Spezialist für Aufbewahrung und Verabreichung injizierbarer... ► Artikel lesen | |
| ELI LILLY | 1.003,60 | +0,02 % | FDA Grants Full Approval To Lilly's Inluriyo Plus Verzenio For ESR1-Mutated Breast Cancer | INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) announced that the U.S. Food and Drug Administration has granted full approval to Inluriyo (imlunestrant), an oral estrogen receptor (ER)... ► Artikel lesen | |
| PFIZER | 24,000 | -0,15 % | Is Pfizer an Excellent Dividend Stock to Buy? | ||
| AQUESTIVE THERAPEUTICS | 4,600 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm (dibutepinephrine) Sublingual Film | Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026FDA will determine the resubmission classification and establish the applicable... ► Artikel lesen | |
| NOVARTIS | 122,44 | +0,18 % | DEUTSCHE BANK RESEARCH stuft NOVARTIS AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Novartis mit einem Kursziel von 120 Franken auf "Hold" belassen. Dies schrieb Emmanuel Papadakis in seiner am Dienstag vorliegenden... ► Artikel lesen |
ZHONG JI LONGEVITY SCIENCE GROUP LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZHONG JI LONGEVITY SCIENCE GROUP LTD finden Sie auf Wallstreet Online.